首页 | 本学科首页   官方微博 | 高级检索  
检索        

氨溴索、酚妥拉明、多巴酚丁胺联合治疗肺源性心脏病顽固性心力衰竭的观察与护理
引用本文:黄琼霞,邓玉芳,何莉衍.氨溴索、酚妥拉明、多巴酚丁胺联合治疗肺源性心脏病顽固性心力衰竭的观察与护理[J].中国医药科学,2012(13):121-122.
作者姓名:黄琼霞  邓玉芳  何莉衍
作者单位:深圳市龙华新区观澜人民医院内科;
摘    要:目的总结氨溴索、酚妥拉明、多巴酚丁胺联合治疗肺心病顽固性心力衰竭的观察与护理体会。方法回顾分析综合治疗加用氨溴索、酚妥拉明、多巴酚丁胺的共70例患者的病情观察与护理,并进行总结。结果 70例患者经过严密的病情观察和有效的护理,显效44例,好转20例,总有效率91.43%。结论严密的病情观察与有效的护理是患者康复存活的重要保证。

关 键 词:肺源性心脏病  顽固性心力衰竭  观察  护理

Effects of ambroxol,phentolamine and dobutamine on refractory heart failure with pulmonary heart disease
Abstract:Objective To summary the clinical observation and nursing of ambroxol,phentolamine and dobutamine combination therapy for pulmonary heart disease refractory heart failure.Methods Retrospective analyzed clinical observation and treatment results of 70 cases subjected to combined treatment using ambroxol,phentolamine and dobutamine.Results 70 cases were treated with the combined treatment above-mentioned.44 cases indicated clear signs of improvement and 20 cases showed stable recovery,implying an total effectiveness of 91.43%.Conclusion Intensive clinical observation and treatment are critical steps for patients' recovery.
Keywords:Pulmonary heart disease  Refractory heart failure  Observation  Care
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号